Clinical trial
Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine…
NCT00480883 · Combined Military Hospital, Pakistan, Other · Completed
Key facts
| NCT number | NCT00480883 |
|---|---|
| Title | Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol |
| Official title | Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate 20 Mg/Kg/Day Versus Meglumine Antimoniate 10 Mg/Kg/Day And Tablet Allopurinol 20 Mg/Kg/Day |
| Lead sponsor | Combined Military Hospital, Pakistan, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Leishmaniasis, Cutaneous |
| Intervention type | Drug |
| Interventions | meglumine antimoniate, allopurinol |
| Enrollment | 400 |
| Start date | Jan 1, 2008 |
| Primary completion | Jun 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | May 31, 2007 |
| Last update posted | Jun 2, 2010 |
| Countries | Pakistan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: